TLR-9

InDex's topical ulcerative colitis drug hits goal in phase 2b
Fierce Biotech
Tue, 08/27/19 - 09:33 am
InDex Pharmaceuticals
ulcerative colitis
TLR-9
Dynavax Initiates Phase 1/2 Study of TLR-9 Agonist Immunotherapy in B-Cell Lymphoma
Yahoo
Mon, 10/13/14 - 07:26 am
Dynavax
TLR-9
immuno-oncology
B-cell lymphoma
SD-101
Dynavax Advances Agonist For Asthma Into The Clinic
Seeking Alpha
Wed, 10/31/12 - 10:49 am
Dynavax
asthma
TLR-9
AZD-1419